Jessa Ziekenhuis — Clinical Trial Site

165 Registered trials

66 Currently recruiting

Organisation

Jessa Ziekenhuis

Location

Hasselt, Belgium

Identifier

ORG-100040398

Address

Stadsomvaart 11, 3500, Belgium

Departments

#2103: Cardiology
032003:Medische Oncologie
0503 : Pneumologie - Thoracale Oncologie
0504: Pneumologie - Thoracale Oncologie
301: Medische Oncologie
4001: Cardiology
Algemeen Medische Oncologie
Anesthesie en intensieve zorgen
Anesthesiologie
Anesthesiology
BEL002: Pneumologie - Thoracale Oncologie
Campus Virga Jesse - Oncology Department
cardiac surgery
Cardiology
Cardiology Department
Cardiology Loc. 1
Datamanagement Oncology
Department of Hematology
Department of Oncology
Dept of Pulmonology and Thoracic Oncology
Gastro-enterology
Gastroenterology
General Medical Oncology
Gynaecology
Hartcentrum Hasselt Research Centre
Hematologie
Hematology
Infectious Diseases
Infectious diseases and Immunity
Intensive care medicine
Lung Diseases
Medical Oncology
Medical Oncology Department
Medische oncologie
N/A
Nephrology
Neurology
Neurology Department
Oncology
Oncology department
Pneumologie - Thoracal oncology
Pneumology
Pneumonology
Pulmonology
Pulmonology & Thoracic Oncology
Pulmunology-Thoracic Oncology
Radiotherapie
radiotherapy
Radiotherapy-oncology
Respiratoire Oncologie
Respiratory Oncology

Clinical trials at this site (165)

Search interface

Clinical trial of MK-7648A in adults and children with skin cancer Not authorised

2022-501417-31-00 High-risk Resected Melanoma 5
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh… Not authorised

2023-505311-20-00 Metastatic Non-Small Cell Lung Cancer 5
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
High versus low dose serratus anterior plane block after minimally invasive valve surgery Pending

2023-508719-22-00 Serratus anterior plane block after an aortic valve rep 6
A trial to learn how well Dato-DXd and rilvegostomig work and how safe they are in participants with stage I adenocarcinoma non-small cell l… Pending

2024-512195-35-00 Stage I adenocarcinoma non-small cell lung cancer (NSCL 5
A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel… Pending

2024-519786-22-01 metastatic non-small cell lung cancer (NSCLC) 9
RESCAP to prevent peri- and post-surgical complications in open-heart surgery. Pending

2025-520551-84-00 systemic inflammation as side-effect of heart-lung mach 5
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
Study to assess the efficacy and safety of Rina-S plus standard of care compared to standard of care for maintenance treatment of participan… Pending

2025-522167-15-00 Ovarian Cancer Platinum-Sensitive Ovarian Cancer (PSOC) 5
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L… Pending

2025-522818-23-00 Small Cell Lung Cancer (SCLC) 5
A Clinical Trial to Compare the Effectiveness and Safety of RO7771950 in Combination with Trastuzumab and Capecitabine, Versus Tucatinib in … Recruiting

2025-524498-17-00 Pretreated Unresectable Locally Advanced or Metastatic 10 2026-05-08
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R… Recruiting

2024-519818-31-01 Endometrial Cancer Advanced, Recurrent, Metastatic, or 5 2026-04-10
A study to learn if DM199 drug is safe and whether it works better than placebo for treating acute ischemic stroke Recruiting

2024-513911-28-00 Acute Ischemic Stroke 10 2026-03-04
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting

2025-522553-19-00 Symptomatic genetic and familial dilated cardiomyopathy 10 2026-02-25
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A Study of Navlimetostat (BMS-986504) in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy… Recruiting

2025-521511-40-00 metastatic non-small cell lung cancer 10 2025-11-18
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemal… Recruiting

2023-507097-41-01 Patients with limited-stage small cell lung cancer (LS- 5 2025-03-20
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
A Phase 1 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Denikitug (GS-1811), an Afucosylated Anti-CCR8 Monoclonal … Recruiting

2022-501684-40-00 Head and Neck Squamous Cell Carcinoma, Non-Small-Cell L 3 2023-10-05
A Phase 3b study to learn more about the safety and tolerability of ivosidenib in combination with azacitidine in adult patients newly diagn… Recruiting

2022-501709-11-00 Isocitrate deshydrogenase1 mutation-positive (IDH1m) ac 5 2023-06-06
Phase 3 Trial of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation Recruiting

2022-503012-16-00 Patients on treatment with Factor Xa Inhibitor needing 5 2022-07-20
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participan… Recruiting

2023-505749-14-00 c-Met overexpressing EGFR wildtype non-squamous non-sma 5 2022-03-20